Skip to main content
. 2011 May 1;11(9):812–815. doi: 10.4161/cbt.11.9.15178

Figure 1.

Figure 1

Correlation between the BCIC and BM-MSC. BM samples from primary breast cancer patients were interrogated for ALDH function using the aldefluor® assay (Stem Cell Technologies, Vancouver, BC). Within the aldefluor+ BM-MNC subset, BCIC phenotype was defined as CD326+CD45CD44+CD24low and its percentage is correlated with BM-MSC that co-expressed GD2 and CD271 (either CD45GD2+CD200+CD271+ or CD45GD2+CD271+).